GFM
DXCM icon

GF Fund Management’s DexCom DXCM Stock Holding History

GF Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.68M Sell
90,482
-2,343
-3% -$163K 0.1% 125
2025
Q4 		$6.16M Buy
92,825
+3,977
+4% +$257K 0.11% 134
2025
Q3 		$5.98M Buy
88,848
+1,780
+2% +$141K 0.11% 133
2025
Q2 		$7.6M Buy
87,068
+2,694
+3% +$211K 0.15% 118
2025
Q1 		$5.76M Buy
84,374
+1,305
+2% +$106K 0.14% 129
2024
Q4 		$6.46M Buy
+83,069
New +$6.15M 0.14% 123

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GF Fund Management's DXCM Position: Q1 2026 in Review

GF Fund Management reduced its DexCom (DXCM) stake by 2.5% in Q1 2026, selling an estimated $163K and leaving 90,482 shares worth $5.68M. The position accounts for 0.1% of the portfolio, ranked #125.

GF Fund Management first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.6M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • GF Fund Management held 90,482 shares of DexCom worth $5.68M as of Q1 2026.
  • GF Fund Management sold 2,343 DexCom shares in Q1 2026, an estimated $163K.
  • DexCom made up 0.1% of GF Fund Management's portfolio in Q1 2026, its #125 holding.
  • GF Fund Management first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's DexCom position peaked at $7.6M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.